Get started
Author

M. Yu. Neronova

Observed names: Maria Neronova, Неронова М. Ю.
Observed institution: Generium Pharmaceuticals (Russia)
ORCID: 0000-0001-6029-4563
Observed ORCID: 0000-0001-6029-4563
OpenAlex ID: A5092370754
Development and validation of a peptide-mapping procedure for a novel C1 esterase inhibitor
2023 · E. V. Zubareva, M. D. Degterev, et al. · Biological Products Prevention Diagnosis Treatment · 2
PDF
Development of acid alpha-glucosidase-producing clones based on the CHO-K1 cell line
2026 · S. S. Timonova, S. S. Shubina, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Therapeutic glycoproteins: sample preparation for N-glycan profiling of monoclonal antibodies
2026 · M. Yu. Neronova, I. A. Kargopolov, et al. · Biological Products Prevention Diagnosis Treatment
Comparative physicochemical and biological characterization of the similar imiglucerase product Glurazyme® and the originator product Cerezyme®
2023 · Maksim Smolov, Serge Taran, et al. · Journal of Pharmaceutical and Biomedical Analysis Open
Works count: 5
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type